Diisopropylphosphorofluoridate-induced muscle hyperactivity associated with enhanced lipid peroxidation in vivo

Biochemical Pharmacology

Volumn 52, Issue 2, 1996, Pages 357-361

  Yang, Zhen P ^a   Morrow, Jason ^a   Wu, Aiping ^a   Roberts II, L Jackson ^a   Dettbarn, Wolf D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

acetylcholinesterase; antioxidant; diisopropylphosphorofluoridate; F2 is oprostanes; lipid peroxidation; oxygen free radicals

Indexed keywords

2 [[4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]METHYL] 3,4 DIHYDRO 2,5,7,8 TETRAMETHYL 2H 1 BENZOPYRAN 6 OL; ANTIOXIDANT; ATROPINE; CHOLINESTERASE INHIBITOR; DYFLOS; FREE RADICAL; LAZAROID; MALONALDEHYDE; NEUROMUSCULAR BLOCKING AGENT; OXYGEN RADICAL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUBOCURARINE CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DIAPHRAGM; FASCICULATION; HYPERACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID PEROXIDATION; MALE; MUSCLE NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030602912     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00214-6     Document Type: Article

References (21)

1. 1. Laskowski MB and Dettbarn W-D, The pharmacology of experimental myopathies. Annu Rev Pharmacol Toxicol 17: 387-409, 1977.
2. 2. Laskowski MB, Olson WH and Dettbarn W-D, Ultrastructural changes at the motor endplate produced by an irreversible cholinesterase inhibitor. Exp Neurol 47: 290-306, 1975.
3. 3. Wecker L, Kiauta T and Dettbarn W-D, Relationship between acetylcholinesterase inhibtion and the development of a myopathy. J Pharmacol Exp Ther 206: 97-104, 1978.
4. 4. Misulis KE, Clinton ME, Dettbarn W-D and Gupta RC, Differences in central and peripheral neural actions between soman and diisopropyl fluorophosphate, organophosphorus inhibitors of acetylcholinesterase. Toxicol Appl Pharmacol 89: 391-398, 1987.
5. 5. Clinton ME, Misulis KE and Dettbarn W-D, Effects of phenytoin, ketamine, and atropine methylnitrate in preventing neuromuscular toxicity of acetylcholinesterase inhibitors soman and diisopropylphosphorofluoridate. J Toxicol Environ Health 24: 439-449, 1988.
6. 6. Wecker L and Dettbarn W-D, Effects of denervation on the production of an experimental myopathy. Exp Neurol 57: 94-100, 1977.
7. 7. Patterson GT, Gupta RC, Misulis KE and Dettbarn W-D, Prevention of diisopropylphosphorofluoridate (DFP)-induced skeletal muscle fiber lesions in rat. Toxicology 48: 237-244, 1988.
8. 8. Sket D, Dettbarn W-D, Clinton ME, Misulis KE, Sketelj J, Cucek D and Brzin M, Prevention of diisopropylphosphorofluoridate-induced myopathy by botulinum toxin type A blockage of quantal release of acetylcholine. Acta Neuropathol (Berl) 82: 134-142, 1991.
9. 9. Yang ZP and Dettbarn W-D, Diisopropylphosphorofluoridate induced cholinergic hyperactivity and lipid peroxidation. Toxicol Appl Pharmacol, in press.
10. 10. Gupta RC and Dettbarn W-D, Alterations of high-energy phosphate compounds in the skeletal muscles of rats intoxicated with diisopropylphosphorofluoridate (DFP) and soman. Fund Appl Toxicol 8: 400-407, 1987.
11. 11. Sjodin B, Westing YH and Apple FS, Biochemical mechanisms for oxygen free radical formation during exercise. Sports Med 10: 236-254, 1990.
12. 2) in diisopropyl fluorophosphate (DFP) induced muscle hyperactivity. FASEB J 9: A694, 1995.
13. 2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA 89: 10721-10725, 1992.
14. 14. Sinnhuber RO and Yu TC, 2-Thiobarbituric acid method for measurement of rancidity in fishery products: II. The quantitative determination of malondialdehyde. Food Technol 12: 9-12, 1957.
15. 15. Largilliere C and Melancon SB, Free malondialdehyde determination in human plasma by high-performance liquid chromatography. Anal. Biochem. 170: 123-126, 1988.
16. 16. Draper HH and Hadley M, Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186: 421-431, 1990.
17. 17. Draper HH, Squires EJ, Mahmoodi H, Wu J, Agarwal S and Hadley M, A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic Biol Med 15: 353-363, 1993.
18. 18. Braughler JM, Hall ED, Jacobsen EJ, McCall JM and Means ED, The 21-aminosteroids: Potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemia. Drugs Future 14: 143-152, 1989.
19. 19. Hall ED, Braughler JM, Yonkers PA, Smith SL, Linseman KL, Means ED, Scherch HM, Von Voigtlander PF, Lahti RA and Jon Jacobsen E, U-78517F: A potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia. J Pharmacol Exp Ther 258: 688-694, 1991.
20. 2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes. Biochem Pharmacol 47: 1173-1177, 1994.
21. 21. Hartman GS, Fiamengo SA and Riker WF, Succinylcholine: Mechanisms of fasciculations and their prevention by d-tubocurarine or diphenylhydantoin. Anesthesiology 65: 405-413, 1986.